Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKanabo Grp Plc Regulatory News (KNB)

  • This share is currently suspended. It was suspended at a price of 0.225

Share Price Information for Kanabo Grp Plc (KNB)

Share Price is delayed by 15 minutes
Get Live Data
0.225    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £1.42m
KNB Live PriceLast checked at - London Stock Exchange

Intraday Kanabo Grp Plc Share Chart

Total Voting Rights

30 Jul 2021 12:49

RNS Number : 1056H
Kanabo Group PLC
30 July 2021
 

30 July 2021

Kanabo Group PLC

("Kanabo" or the "Company")

Total Voting Rights

For the purposes of the Financial Conduct Authority's Disclosure Guidance and Transparency Rules, Kanabo Group Plc announces that the Company has 368,925,073 ordinary shares of 2.5p each in issue ("Ordinary Shares"), each share carrying the right to one vote. The figure of 368,925,073 should be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

The Directors of the Company accept responsibility for the contents of this announcement.

For further information, please visit http://www.kanabogroup.com/ or contact the following:

Kanabo Group Plc

+(972)52-3173-633

press@kanabogroup.com

Meirav Horn

 

Peterhouse Capital Limited (Financial Adviser)

Tel: +44 (0)20 7469 0930

Eran Zucker / Guy Miller

 

Peterhouse Capital Limited (Corporate Broker)

Lucy Williams / Charles Goodfellow

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRFBLFXFDLZBBV
Date   Source Headline
21st Apr 20212:57 pmRNSIssue of Equity
14th Apr 20214:01 pmRNSIssue of Equity
8th Apr 20213:15 pmRNSQ1 Summary
31st Mar 20214:51 pmRNSTotal Voting Rights
30th Mar 20213:26 pmRNSIssue of Equity
26th Mar 20217:00 amRNSPDMR Notification
23rd Mar 20218:47 amRNSPublication of Research Note
16th Mar 20212:42 pmRNSIssue of Equity
9th Mar 202111:06 amRNSSecond Price Monitoring Extn
9th Mar 202111:00 amRNSPrice Monitoring Extension
9th Mar 20217:00 amRNSMedicinal Cannabis Production Agreement
8th Mar 20213:42 pmRNSChange of Registered Address
23rd Feb 20217:00 amRNSUK Medicinal Cannabis Distribution Agreement
22nd Feb 20219:05 amRNSSecond Price Monitoring Extn
22nd Feb 20219:00 amRNSPrice Monitoring Extension
19th Feb 20219:05 amRNSSecond Price Monitoring Extn
19th Feb 20219:00 amRNSPrice Monitoring Extension
18th Feb 20214:41 pmRNSSecond Price Monitoring Extn
18th Feb 20214:36 pmRNSPrice Monitoring Extension
18th Feb 20219:05 amRNSSecond Price Monitoring Extn
18th Feb 20219:00 amRNSPrice Monitoring Extension
17th Feb 20214:40 pmRNSSecond Price Monitoring Extn
17th Feb 20214:35 pmRNSPrice Monitoring Extension
17th Feb 20212:06 pmRNSSecond Price Monitoring Extn
17th Feb 20212:01 pmRNSPrice Monitoring Extension
17th Feb 202111:05 amRNSSecond Price Monitoring Extn
17th Feb 202111:00 amRNSPrice Monitoring Extension
17th Feb 20219:05 amRNSSecond Price Monitoring Extn
17th Feb 20219:00 amRNSPrice Monitoring Extension
16th Feb 20212:05 pmRNSSecond Price Monitoring Extn
16th Feb 20212:01 pmRNSPrice Monitoring Extension
16th Feb 20217:00 amRNSAdmission and First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.